Stemtech Announces Leadership Additions and StemPets™ Launch in Q2 2025

Stemtech (OTCQB:STEK), a global leader in stem cell nutrition, is proud to announce strategic leadership appointments and the upcoming launch of its highly anticipated StemPets™ product line. Committed to enhancing health for individuals and pets alike, Stemtech continues to drive innovation in the wellness space.

StemPets™: A Game Changer in Pet Health

Stemtech is set to launch StemPets in early Q2 of 2025, marking its entry into the booming pet healthcare sector, projected to exceed $303 billion by 2027.

John W. Meyer, President & COO of Stemtech said:

“We are excited to bring the power of stem cell nutrition to pets, offering a breakthrough solution for pet owners. StemPets is a game changer in pet care, uniquely positioning us to capture market growth with science-backed products.”

Strategic Leadership Appointments

To drive global expansion, Stemtech welcomes key executives:

• Alejandro Carrillo, Vice President of Global Operations, will oversee manufacturing, inventory, and expansion management.
• Srilakshmi Vadlapatla, Global Accounts Manager and future CFO, will lead financial strategy, bringing vast experience in international finance.
• Manuel Ramirez Garcia, Director of Global Sales & Field Development, will spearhead global sales strategy and market expansion, leveraging over 20 years of experience.

“We are thrilled to have Srilakshmi and Manuel join our leadership team and Alex in his new role. Their expertise in finance, global sales, and operations will drive Stemtech’s continued growth and innovation.”

said Meyer.

Stemtech extends gratitude to outgoing CFO James S. ‘Jay’ Cardwell for his invaluable contributions.

Expanding Innovation & Market Leadership

Stemtech is positioned as a pioneer in stem cell nutrition, with a diverse portfolio of natural health solutions, including StemRelease3™, StemFlo™ Advanced, and OraStem® Toothpaste. The company’s latest launch, Cellect One® Shield, and its upcoming April 2025 debut of StemPets™, highlight Stemtech’s continued innovation.

Charles S. Arnold, Chairman and CEO shared:

“We are entering an exciting chapter of growth. The launch of StemPets and our strengthened leadership team position us to lead the pet healthcare market. We look forward to transforming lives and helping families enjoy healthier, happier lives with their pets.”

About StemTech

For nearly 20 years, Stemtech has not only championed the benefits of natural, plant-based ingredients but has also led the way in scientific innovation within the wellness, anti-aging, and longevity sectors. As industry forecasts and studies from reputable sources like the Global Wellness Institute project unprecedented growth, Stemtech’s unwavering commitment to quality and innovation ensures that they will remain at the forefront of this transformative journey-making everyone healthier, while slowing down the aging process naturally.